Buys | $0 | 0 | 0 |
Sells | $3,461,423 | 14 | 100 |
Llorens Josep | EVP, Global Manufacturing | 0 | $0 | 3 | $245,814 | $-245,814 |
Lingamneni Anila | EVP, Chief Technology Officer | 0 | $0 | 3 | $418,325 | $-418,325 |
Strong Stewart W | President, Global Hospital | 0 | $0 | 4 | $1.3M | $-1.3M |
Basil Michelle L | EVP and General Counsel | 0 | $0 | 4 | $1.49M | $-1.49M |
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides …
Over the last 12 months, insiders at Haemonetics Corporation have bought $0 and sold $3.46M worth of Haemonetics Corporation stock.
On average, over the past 5 years, insiders at Haemonetics Corporation have bought $323,720 and sold $5.96M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $323,720 was made by ABERNATHY ROBERT E (director) on 2020‑08‑11.
2024-07-26 | Sale | Strong Stewart W | President, Global Hospital | 4,312 0.0085% | $91.15 | $393,039 | -17.26% | |
2024-07-12 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 79 0.0002% | $90.00 | $7,110 | -16.65% | |
2024-07-11 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,136 0.0045% | $90.00 | $192,240 | -15.61% | |
2024-05-29 | Sale | Basil Michelle L | EVP and General Counsel | 12,990 0.0257% | $88.08 | $1.14M | -12.51% | |
2024-05-29 | Sale | Strong Stewart W | President, Global Hospital | 8,857 0.0174% | $87.53 | $775,253 | -12.51% | |
2024-05-20 | Sale | Basil Michelle L | EVP and General Counsel | 1,604 0.0032% | $95.08 | $152,508 | -19.52% | |
2024-05-20 | Sale | Llorens Josep | EVP, Global Manufacturing | 987 0.0019% | $95.08 | $93,844 | -19.52% | |
2024-05-20 | Sale | Strong Stewart W | President, Global Hospital | 686 0.0013% | $95.11 | $65,245 | -19.52% | |
2024-05-17 | Sale | Basil Michelle L | EVP and General Counsel | 1,073 0.0021% | $95.00 | $101,935 | -19.90% | |
2024-05-17 | Sale | Llorens Josep | EVP, Global Manufacturing | 822 0.0016% | $94.82 | $77,942 | -19.90% | |
2024-05-16 | Sale | Basil Michelle L | EVP and General Counsel | 985 0.002% | $96.14 | $94,698 | -19.11% | |
2024-05-16 | Sale | Llorens Josep | EVP, Global Manufacturing | 770 0.0015% | $96.14 | $74,028 | -19.11% | |
2024-05-16 | Sale | Strong Stewart W | President, Global Hospital | 733 0.0015% | $96.04 | $70,397 | -19.11% | |
2024-05-06 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,305 0.0045% | $95.00 | $218,975 | -19.24% | |
2023-09-12 | Sale | Strong Stewart W | President, Global Hospital | 228 0.0005% | $90.65 | $20,668 | -5.54% | |
2023-09-11 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,305 0.0045% | $90.00 | $207,450 | -6.30% | |
2023-09-05 | Sale | Dockendorff Charles J | director | 10,215 0.0202% | $87.68 | $895,651 | -2.36% | |
2023-07-18 | Sale | Llorens Josep | EVP, Global Manufacturing | 4,928 0.0095% | $90.00 | $443,520 | -6.20% | |
2023-06-07 | Sale | Strong Stewart W | President, Global Hospital | 2,538 0.005% | $88.04 | $223,446 | -2.39% | |
2023-05-30 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,304 0.0045% | $83.33 | $191,992 | +3.00% |
Simon, Christopher | President & CEO | 213724 0.4254% | $13.69M | 1 | 21 | +13.41% |
CONCANNON BRIAN | President & CEO | 147040 0.2927% | $9.42M | 8 | 57 | +8.69% |
GELBMAN RONALD G | director | 48384 0.0963% | $3.1M | 1 | 16 | +4.67% |
LINDOP CHRISTOPHER J | CFO & EVP Business Development | 45350 0.0903% | $2.9M | 12 | 15 | +4.66% |
ALLEN PETER M | President, Global Plasma | 34102 0.0679% | $2.18M | 20 | 22 | +7.23% |
Increased Positions | 172 | +54.09% | 4M | +7.25% |
Decreased Positions | 135 | -42.45% | 3M | -5.88% |
New Positions | 49 | New | 817,428 | New |
Sold Out Positions | 44 | Sold Out | 473,873 | Sold Out |
Total Postitions | 355 | +11.64% | 57M | +1.38% |
Blackrock, Inc. | $389,244.00 | 12.32% | 6.16M | -54,472 | -0.88% | 2024-12-31 |
Vanguard Group Inc | $327,286.00 | 10.36% | 5.18M | +10,119 | +0.2% | 2024-12-31 |
Neuberger Berman Group Llc | $279,258.00 | 8.84% | 4.42M | +392,240 | +9.74% | 2024-12-31 |
Capital Research Global Investors | $267,860.00 | 8.48% | 4.24M | -203,699 | -4.58% | 2024-12-31 |
Wellington Management Group Llp | $248,983.00 | 7.88% | 3.94M | -261,341 | -6.22% | 2024-12-31 |
T. Rowe Price Investment Management, Inc. | $161,376.00 | 5.11% | 2.55M | -296,823 | -10.41% | 2024-12-31 |
State Street Corp | $123,030.00 | 3.89% | 1.95M | +58,494 | +3.1% | 2024-12-31 |
Thrivent Financial For Lutherans | $79,891.00 | 2.53% | 1.26M | +164,111 | +14.92% | 2024-12-31 |
Geode Capital Management, Llc | $74,630.00 | 2.36% | 1.18M | -12,878 | -1.08% | 2024-12-31 |
Royce & Associates Lp | $72,875.00 | 2.31% | 1.15M | -57,278 | -4.73% | 2024-12-31 |